Mirae Asset Global ETFs Holdings’s LENZ Therapeutics LENZ Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio LENZ Stock Details LENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$53.6K	Buy	9,438 +67	+0.7%	+$540	﹤0.01%	3027
2026 Q1	$85.7K	Buy	9,371 +1,836	+24%	+$25.8K	﹤0.01%	2730
2025 Q4	$121K	Buy	7,535 +55	+0.7%	+$1.6K	﹤0.01%	2582
2025 Q3	$348K	Sell	7,480 -2,267	-23%	-$83.4K	﹤0.01%	2041
2025 Q2	$286K	Buy	9,747 +2,222	+30%	+$60.4K	﹤0.01%	2092
2025 Q1	$193K	Sell	7,525 -389	-5%	-$9.58K	﹤0.01%	2339
2024 Q4	$229K	Buy	7,914 +1,005	+15%	+$30.6K	﹤0.01%	2324
2024 Q3	$164K	Buy	6,909 +5,282	+325%	+$117K	﹤0.01%	2470
2024 Q2	$28.1K	Buy	+1,627	New	+$28.4K	﹤0.01%	2881

Other funds holding LENZ

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

7IH

72 Investment Holdings Stamford, Connecticut $50M AUM 647.58% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's LENZ Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its LENZ Therapeutics (LENZ) stake by 0.71% in Q2 2026, buying an estimated $540 and bringing the position to 9,438 shares worth $53.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3027.

Mirae Asset Global ETFs Holdings first reported a position in LENZ in Q2 2024 and has held it in 9 quarters since. The position peaked at $348K in Q3 2025. 145 funds tracked by Wall St. Rank hold LENZ as of Q2 2026.

Mirae Asset Global ETFs Holdings held 9,438 shares of LENZ Therapeutics worth $53.6K as of Q2 2026.
Mirae Asset Global ETFs Holdings bought 67 LENZ Therapeutics shares in Q2 2026, an estimated $540.
LENZ Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #3027 holding.
Mirae Asset Global ETFs Holdings first reported a position in LENZ Therapeutics in Q2 2024 and has held it in 9 quarters since.
Mirae Asset Global ETFs Holdings's LENZ Therapeutics position peaked at $348K in Q3 2025.
145 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.